Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Treasury Shares (2016 - 2017)

Bone Biologics has reported Treasury Shares over the past 3 years, most recently at $1.0 million for Q4 2017.

  • Quarterly Treasury Shares fell 90.12% to $1.0 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2017, down 90.12% year-over-year, with the annual reading at $1.0 million for FY2017, 90.12% down from the prior year.
  • Treasury Shares was $1.0 million for Q4 2017 at Bone Biologics, down from $10.4 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $10.4 million in Q4 2016 and troughed at $1.0 million in Q4 2017.
  • The 3-year median for Treasury Shares is $9.8 million (2015), against an average of $7.1 million.
  • Year-over-year, Treasury Shares grew 6.25% in 2016 and then crashed 90.12% in 2017.
  • A 3-year view of Treasury Shares shows it stood at $9.8 million in 2015, then grew by 6.25% to $10.4 million in 2016, then crashed by 90.12% to $1.0 million in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Treasury Shares are $1.0 million (Q4 2017), $10.4 million (Q4 2016), and $9.8 million (Q4 2015).